BREA,
Calif., Oct. 17, 2023 /PRNewswire/ -- Life Science
Outsourcing, Inc. ("LSO"), a premier contract manufacturer and
value-added service provider for the medical device and life
science sectors, announces the appointment of Neil A. Goldman, CPA, as its new Chief Financial
Officer ("CFO"), effective October 16,
2023. With this significant move, LSO reaffirms its
dedication to innovation, growth, and service excellence.
Mr. Goldman joins LSO from BioPorto A/S (CPH:BIOPOR), a global
developer and manufacturer of kidney diagnostics and a portfolio of
antibodies. At BioPorto, where Mr. Goldman served as Executive Vice
President and CFO, he raised over DKK 140 million to fund
the Company through timely completion of its clinical trials and
review by the US Food and Drug Administration.
CEO John Nino commented on the
appointment, stating, "We are excited to welcome Neil to our
executive team. With his impressive track record in the industry
and breadth of experience building teams, scaling operations, and
driving business through organic growth and strategic
relationships, we are confident he will be instrumental in LSO's
continued success and growth."
Previously, Mr. Goldman was an executive at Chembio Diagnostics,
Inc. (formerly NASDAQ:CEMI), J.S. Held LLC, and Unwired Technology
LLC. As Executive Vice President and CFO of Chembio, he drove
transformative milestones, including a significant revenue boost,
an expanded institutional shareholder base, and two foreign
acquisitions. At J.S. Held, where he served as Executive Vice
President-Corporate Development and CFO, he helped lead substantial
sales and EBITDA growth, including closing a series of
acquisitions. At Unwired, a hi-tech, tier-1 automotive electronics
manufacturer, he held positions including Executive Vice
President-Corporate Development and CFO, and Senior Vice
President-Chief Operating & Financial Officer. He joined Delphi
Corp., now Aptiv plc (NYSE:APTV), following Delphi's acquisition of
Unwired, which delivered a significant return on investment for
shareholders.
Mr. Goldman began his career at Ernst & Young, where he was
an auditor of Fortune 500 manufacturers and advanced into regional
and national management consulting positions.
He holds a B.S. in Business-Accountancy from Miami University in Oxford, Ohio, US.
John Nino further stated, "With
Neil onboard, LSO is poised to fortify its position as a premier
Contract Manufacturing Organization. We look forward to the new
horizons and possibilities his leadership and expertise will unlock
for our company."
About Life Science Outsourcing
Life Science Outsourcing is an FDA-registered and ISO
13485-certified Contract Manufacturing Organization with over
125,000 sq ft of bicoastal production operations with cleanroom
capabilities, including locations in Brea, CA, Somersworth, NH, and nearshore options in
Costa Rica. We focus on assembly,
packaging, sterilization, and specialized capabilities in
diagnostics precision reagent packaging & design. Our unique
business model emphasizes in-house, end-to-end process and service
offerings, coupled with deep regulatory knowledge. This provides
the agility and flexibility necessary to accelerate go-to-market
launches, while standardizing supply chain and mitigating risk. For
more information, please visit www.lso-inc.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/life-science-outsourcing-inc-welcomes-neil-a-goldman-as-chief-financial-officer-301958348.html
SOURCE Life Science Outsourcing, Inc.